Heart attacks (myocardial infarctions – MI) remain one of the leading causes of death and morbidity in Israel and the Western world. Over the past two decades, treatment outcomes have advanced significantly thanks to early catheterization and advancements in pharmacological therapy.
The Sheba Cardiovascular and Thoracic Institute, one of the world’s largest and most respected cardiac centers, treats hundreds of patients each year following cardiac events.
To better understand recovery beyond clinical complications, Sheba launched one of the world’s most advanced Patient-Reported Outcome Measures (PROMs) projects for post-MI care. The initiative focuses on patients’ quality of life and symptom improvement following therapeutic catheterization. The main outcomes:
85% of patients who suffered from shortness of breath during or before their MI reported no such symptoms one year post-catheterization.
76% of patients who suffered from angina pectoris were symptom-free one year after the procedure.
These outcomes highlight improvements in patient quality of life.
